SIEWERT TYPE I ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION

Clinical trials for SIEWERT TYPE I ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION explained in plain language.

Never miss a new study

Get alerted when new SIEWERT TYPE I ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION trials appear

Sign up with your email to follow new studies for SIEWERT TYPE I ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill shows promise in shrinking esophageal tumors before surgery

Disease control Terminated

This study tests whether adding a pill called vactosertib to standard chemoradiation can improve outcomes for people with locally advanced esophageal cancer. Participants take vactosertib for two weeks before and after standard therapy, then undergo surgery. The goal is to see if…

Matched conditions: SIEWERT TYPE I ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION

Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control

Last updated May 17, 2026 05:56 UTC

SIEWERT TYPE I ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION

Get alerted when new SIEWERT TYPE I ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION trials appear

New pill shows promise in shrinking esophageal tumors before surgery